Zainab Tiamiyu
Research Subjects
Research Interests
Zainab Tiamiyu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Kebin Liu
Georgia Cancer Center, Augusta University, Augusta, Georgia, USA
12 shared publications - Dafeng Yang
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, Georgia
11 shared publications - Dakota B. Poschel
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, Georgia
11 shared publications - Kendra Fick
Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, Georgia
11 shared publications - Martina Zoccheddu
Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia
11 shared publications - Miao Yu
Georgia Cancer Center, Medical College of Georgia, Augusta University, Augusta, Georgia
11 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S3 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S3 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Data from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
Despite the breakthrough in immune checkpoint inhibitor (ICI) immunotherapy in human cancer, colon cancer, except for the small subset of microsatellite instable human colon cancer, does not respond to ICI immunotherapy. As liver metastasis accounts for more than 90% of human colon cancer cases and mortality, ICI efficacy is primarily a measurement of liver metastasis suppression. Using a colon tumor liver metastasis syngeneic mouse model, we determined that mouse colon tumor liver metastases not only do not respond to anti–PD-1 immunotherapy but also exhibit no susceptibility to tumor-specific cytotoxic T lymphocyte (CTL) adoptive transfer immunotherapy. Analysis of human colon cancer liver metastases single-cell RNA sequencing (scRNA-seq) datasets revealed that histone methyltransferases of histone 3 lysine 9 trimethylation (H3K9me3) are upregulated in colon tumors and expressed in subsets of T cells in liver metastases of patients with human colon cancer. Targeted therapy with the H3K9me3-specific histone methyltransferase inhibitor F5446 suppresses colon tumor liver metastasis. scRNA-seq analysis revealed the accumulation of PD-1+Tim3+ exhausted T (Tex) cells in mouse colon tumor liver metastases, and F5446 treatment increased the level of IFNγhighPD-1low Tex cells. Furthermore, F5446 therapy increased IFNγhigh intermediate Tex (Tex-int) cells in human colon cancer patient liver metastases–derived xenografts (PDX) and suppressed PDX growth in humanized mice. In patients with human colon cancer, response to pembrolizumab is associated with tumor-infiltrating IFNγhigh Tex cells. Our findings determine that H3K9me3 promotes differentiation of Tex cells and targeting H3K9me3 is an effective approach to increase IFNγhigh Tex-int cells to reinvigorate CTL functionality to suppress colon cancer liver metastasis.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
Despite the breakthrough in immune checkpoint inhibitor (ICI) immunotherapy in human cancer, colon cancer, except for the small subset of microsatellite instable human colon cancer, does not respond to ICI immunotherapy. As liver metastasis accounts for more than 90% of human colon cancer cases and mortality, ICI efficacy is primarily a measurement of liver metastasis suppression. Using a colon tumor liver metastasis syngeneic mouse model, we determined that mouse colon tumor liver metastases not only do not respond to anti–PD-1 immunotherapy but also exhibit no susceptibility to tumor-specific cytotoxic T lymphocyte (CTL) adoptive transfer immunotherapy. Analysis of human colon cancer liver metastases single-cell RNA sequencing (scRNA-seq) datasets revealed that histone methyltransferases of histone 3 lysine 9 trimethylation (H3K9me3) are upregulated in colon tumors and expressed in subsets of T cells in liver metastases of patients with human colon cancer. Targeted therapy with the H3K9me3-specific histone methyltransferase inhibitor F5446 suppresses colon tumor liver metastasis. scRNA-seq analysis revealed the accumulation of PD-1+Tim3+ exhausted T (Tex) cells in mouse colon tumor liver metastases, and F5446 treatment increased the level of IFNγhighPD-1low Tex cells. Furthermore, F5446 therapy increased IFNγhigh intermediate Tex (Tex-int) cells in human colon cancer patient liver metastases–derived xenografts (PDX) and suppressed PDX growth in humanized mice. In patients with human colon cancer, response to pembrolizumab is associated with tumor-infiltrating IFNγhigh Tex cells. Our findings determine that H3K9me3 promotes differentiation of Tex cells and targeting H3K9me3 is an effective approach to increase IFNγhigh Tex-int cells to reinvigorate CTL functionality to suppress colon cancer liver metastasis.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S6 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S6 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Supplementary figures and tables from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
Combined Supplementary figures and tables.
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figures and tables from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
Combined Supplementary figures and tables.
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S1 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S1 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- Open Access
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis
- 3 November 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from H3K9me3 Regulates IFNγlow Tex Cell Differentiation to Promote Colon Tumor Liver Metastasis